47045-GUY-T-MOH-1 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>Enhancing and Strengthening Tuberculosis services in Key populations across Guyana - Guyana (01-Apr-2016-31-Mar-2019)</narrative> Guyana, Tuberculosis, Ministry of Health of the Co-operative Republic of Guyana Goals: Reduce the burden of TB by improved management of TB/HIV co-infection. To reduce TB/HIV co-infection to under 10% by 2018; Reduce the emergence of MDR-TB by improving case detection (of over 90% of MDR-TB cases) and first line treatment success rate (to over 85% by 2018); Reduce the transmission of TB by higher cases detection (from 75% in 2013 to over 90% in 2018) and treatment of cases. Objectives: Early diagnosis of tuberculosis including universal drug-susceptibility testing; Improve treatment and support of all TB cases including drug-resistant tuberculosis; Increase screening of TB contacts and high-risk groups; Strengthen collaborative TB/HIV and other co-morbid related activities. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health of the Co-operative Republic of Guyana Ministry of Health of the Co-operative Republic of Guyana The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division Marcos Patino Mayer Fund Portfolio Manager +41 58 791 1700 marcos.patinomayer@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Guyana Tuberculosis Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases 580925.00 Global Fund commitment to GUY-T-MOHP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health of the Co-operative Republic of Guyana 151532.00 Global Fund disbursement to GUY-T-MOHP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health of the Co-operative Republic of Guyana 81530.00 Global Fund disbursement to GUY-T-MOHP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health of the Co-operative Republic of Guyana 25000.00 Global Fund disbursement to GUY-T-MOHP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health of the Co-operative Republic of Guyana 46836.00 Global Fund disbursement to GUY-T-MOHP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health of the Co-operative Republic of Guyana 60904.00 Global Fund disbursement to GUY-T-MOHP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health of the Co-operative Republic of Guyana 272734.00 Global Fund commitment to GUY-T-MOHP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health of the Co-operative Republic of Guyana -215123.00 Global Fund commitment to GUY-T-MOHP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health of the Co-operative Republic of Guyana 173804.00 Global Fund disbursement to GUY-T-MOHP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health of the Co-operative Republic of Guyana 25000.00 Global Fund commitment to GUY-T-MOHP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health of the Co-operative Republic of Guyana 43799.00 Global Fund disbursement to GUY-T-MOHP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health of the Co-operative Republic of Guyana 25000.00 Global Fund disbursement to GUY-T-MOHP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health of the Co-operative Republic of Guyana 25000.00 Global Fund commitment to GUY-T-MOHP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health of the Co-operative Republic of Guyana 55131.00 Global Fund disbursement to GUY-T-MOHP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health of the Co-operative Republic of Guyana 108606.93 Global Fund commitment to GUY-T-MOHP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health of the Co-operative Republic of Guyana 25000.00 Global Fund disbursement to GUY-T-MOHP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health of the Co-operative Republic of Guyana -108606.93 Global Fund commitment to GUY-T-MOHP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health of the Co-operative Republic of Guyana <narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime. <narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative>MDR TB- other 1: Number of cases with drug resistant TB (RR-TB and/or MDR-TB) that started on treatment for MDR-TB that are culture negatives at six months</narrative> Module: MDR-TB. <narrative>MDR TB- other 1: Number of cases with drug resistant TB (RR-TB and/or MDR-TB) that started on treatment for MDR-TB that are culture negatives at six months</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 1; Denominator: 4. Numerator: 2; Denominator: 5. Numerator: 2; Denominator: 5. Numerator: 10; Denominator: 14. Numerator: 3; Denominator: 4. Numerator: 15; Denominator: 19. Numerator: 7; Denominator: 15. <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Module: MDR-TB. <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 4; Denominator: 28. Numerator: 16; Denominator: 31. Numerator: 10; Denominator: 31. Numerator: 23; Denominator: 31. Numerator: 15; Denominator: 31. Numerator: 28; Denominator: 31. Numerator: 17; Denominator: 31. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Module: MDR-TB. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 4; Denominator: 4. Numerator: 14; Denominator: 14. Numerator: 10; Denominator: 10. Numerator: 19; Denominator: 19. Numerator: 15; Denominator: 15. Numerator: 27; Denominator: 27. Numerator: 17; Denominator: 17. <narrative>Percentage of cases with RR-TB and/or MDR-TB started on treatment for MDR-TB who were lost to follow up during the first six months of treatment</narrative> Module: MDR-TB. <narrative>Percentage of cases with RR-TB and/or MDR-TB started on treatment for MDR-TB who were lost to follow up during the first six months of treatment</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 1; Denominator: 4. Numerator: 2; Denominator: 9. Numerator: 0; Denominator: 5. Numerator: 2; Denominator: 17. Numerator: 1; Denominator: 8. Numerator: 2; Denominator: 23. Numerator: 4; Denominator: 18. <narrative>Percentage of previously treated TB patients receiving DST (bacteriologically positive cases only)</narrative> Module: MDR-TB. <narrative>Percentage of previously treated TB patients receiving DST (bacteriologically positive cases only)</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 41; Denominator: 150. Numerator: 97; Denominator: 162. Numerator: 25; Denominator: 81. Numerator: 131; Denominator: 164. Numerator: 67; Denominator: 74. Numerator: 148; Denominator: 164. Numerator: 72; Denominator: 82. <narrative>Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative> Module: RSSH: Health management information systems and M&E. <narrative>Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 12; Denominator: 24. Numerator: 18; Denominator: 26. Numerator: 22; Denominator: 24. Numerator: 24; Denominator: 28. Numerator: 20; Denominator: 25. Numerator: 30; Denominator: 30. Numerator: 23; Denominator: 25. <narrative>Number of TB cases (all forms) notified among key affected populations/high risk groups</narrative> Module: TB care and prevention. <narrative>Number of TB cases (all forms) notified among key affected populations/high risk groups</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 308; Denominator: 648. Numerator: 361; Denominator: 704. Numerator: 204; Denominator: 704. Numerator: 388; Denominator: 712. Numerator: 331; Denominator: 458. Numerator: 413; Denominator: 715. Numerator: 248; Denominator: 468. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Module: TB care and prevention. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 648; Denominator: 945; Percentage: 69%. Numerator: 704; Denominator: 880; Percentage: 80%. Numerator: 577; Denominator: 880; Percentage: 65.6%. Numerator: 712; Denominator: 837; Percentage: 85.1%. Numerator: 526. Numerator: 715; Denominator: 794; Percentage: 90.1%. Numerator: 516; Denominator: 794; Percentage: 65%. <narrative>Number of notified cases of bacteriologically confirmed TB, new and relapses</narrative> Module: TB care and prevention. <narrative>Number of notified cases of bacteriologically confirmed TB, new and relapses</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 303; Denominator: 545; Percentage: 55.6%. Numerator: 413; Denominator: 590; Percentage: 70%. Numerator: 374; Denominator: 590; Percentage: 63.4%. Numerator: 477; Denominator: 596; Percentage: 80%. Numerator: 331. Numerator: 509; Denominator: 599; Percentage: 85%. Numerator: 377; Denominator: 599; Percentage: 62.9%. <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative> Module: TB care and prevention. <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 8; Denominator: 18. Numerator: 18; Denominator: 18. Numerator: 12; Denominator: 18. Numerator: 24; Denominator: 22. Numerator: 15; Denominator: 19. Numerator: 24; Denominator: 24. Numerator: 13; Denominator: 16. <narrative>Percentage of notified TB cases, all forms, contributed by non-NTP providers - community referrals</narrative> Module: TB care and prevention. <narrative>Percentage of notified TB cases, all forms, contributed by non-NTP providers - community referrals</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 55; Denominator: 305. Numerator: 87; Denominator: 361. Numerator: 113; Denominator: 506. Numerator: 109; Denominator: 388. Numerator: 62; Denominator: 331. Numerator: 136; Denominator: 413. Numerator: 82; Denominator: 248. <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative> Module: TB care and prevention. <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 505; Denominator: 785. Numerator: 493; Denominator: 704. Numerator: 364; Denominator: 536. Numerator: 548; Denominator: 712. Numerator: 384; Denominator: 539. Numerator: 608; Denominator: 715. Numerator: 364; Denominator: 505. <narrative>Percentage of HIV-positive patients who were screened for TB in HIV care or treatment settings</narrative> Module: TB/HIV. <narrative>Percentage of HIV-positive patients who were screened for TB in HIV care or treatment settings</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 4811; Denominator: 4931. Numerator: 5222; Denominator: 6143. Numerator: 5298; Denominator: 5315. Numerator: 6080; Denominator: 6755. Numerator: 5134; Denominator: 5543. Numerator: 7003; Denominator: 7372. <narrative>Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment</narrative> Module: TB/HIV. <narrative>Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 103; Denominator: 148. Numerator: 131; Denominator: 164. Numerator: 117; Denominator: 142. Numerator: 142; Denominator: 167. Numerator: 112; Denominator: 138. Numerator: 153; Denominator: 170. Numerator: 84; Denominator: 96. <narrative>Percentage of TB patients who had an HIV test result recorded in the TB register</narrative> Module: TB/HIV. <narrative>Percentage of TB patients who had an HIV test result recorded in the TB register</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 587; Denominator: 648. Numerator: 655; Denominator: 704. Numerator: 592; Denominator: 647. Numerator: 669; Denominator: 712. Numerator: 503; Denominator: 581. Numerator: 679; Denominator: 715. Numerator: 510; Denominator: 586. <narrative>Percentage of new HIV-positive patients starting IPT during the reporting period</narrative> Module: TB/HIV. <narrative>Percentage of new HIV-positive patients starting IPT during the reporting period</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 44; Denominator: 605. Numerator: 306; Denominator: 612. Numerator: 45; Denominator: 530. Numerator: 459; Denominator: 612. Numerator: 91; Denominator: 641. Numerator: 555; Denominator: 617. <narrative>TB/HIV-other 1: Percentage of HIV-positive registered TB patients given CPT during TB treatment</narrative> Module: TB/HIV. <narrative>TB/HIV-other 1: Percentage of HIV-positive registered TB patients given CPT during TB treatment</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 135; Denominator: 148. Numerator: 156; Denominator: 164. Numerator: 142; Denominator: 142. Numerator: 159; Denominator: 167. Numerator: 161; Denominator: 170. Numerator: 95; Denominator: 95. 47045-GUY-T-MOH-2 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>Enhancing and strengthening tuberculosis services in key populations across Guyana - Guyana (01-Apr-2019-31-Dec-2021)</narrative> Guyana, Tuberculosis, Ministry of Health of the Co-operative Republic of Guyana Goals: Reduce TB related mortality to 7 per 100,000 by 2021; Reduce TB incidence to 55 per 100,000 by 2021; Improvecase detection of RR-TB/MDR-TB to at least 85% by 2021; Reduce TB/HIV related mortality to 3 per 100,000 by 2021. Objectives: Increase case detection of TB all forms to over 90% by 2021; Increase case detection of RR-TB/MDR-TB to over 85% by 2021; Increase TB treatment success for TB all forms to over 90% by 2021; Increase TB treatment success for RR-TB/MDR-TB to over 85% by 2021; Increase ART coverage among TB/HIV patients to 100% by 2021; Increase IPT among newly enrolled PLHIV with TB to over 30% by 2021. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health of the Co-operative Republic of Guyana Ministry of Health of the Co-operative Republic of Guyana The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division Marcos Patino Mayer Fund Portfolio Manager +41 58 791 1700 marcos.patinomayer@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Guyana Tuberculosis Multicomponent, RSSH Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases Achieve universal health coverage Multicomponent -> Program management -> Coordination and management of national disease control programs Multicomponent -> Program management -> Grant management RSSH -> RSSH: Health management information systems and M&E -> Analysis, evaluations, reviews and transparency RSSH -> RSSH: Health management information systems and M&E -> Routine reporting RSSH -> RSSH: Health management information systems and M&E -> Surveys Tuberculosis -> MDR-TB -> Case detection and diagnosis (MDR-TB) Tuberculosis -> MDR-TB -> Other MDR-TB intervention(s) Tuberculosis -> MDR-TB -> Treatment (MDR-TB) Tuberculosis -> TB care and prevention -> Community TB care delivery Tuberculosis -> TB care and prevention -> Key populations (TB care and prevention) - Prisoners Tuberculosis -> TB care and prevention -> Treatment (TB care and prevention) Tuberculosis -> TB/HIV -> Engaging all care providers (TB/HIV) Tuberculosis -> TB/HIV -> Key populations (TB/HIV) - Others 31331.14 204081.38 222871.71 209345.67 Global Fund commitment to GUY-T-MOHP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health of the Co-operative Republic of Guyana 37897.00 Global Fund disbursement to GUY-T-MOHP02 (Government). The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health of the Co-operative Republic of Guyana 31140.87 Global Fund commitment to GUY-T-MOHP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health of the Co-operative Republic of Guyana -171448.67 Global Fund commitment to GUY-T-MOHP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health of the Co-operative Republic of Guyana 7681.87 Global Fund disbursement to GUY-T-MOHP02 (Government). The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health of the Co-operative Republic of Guyana 20631.91 Global Fund disbursement to GUY-T-MOHP02 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health of the Co-operative Republic of Guyana 25000.00 Global Fund commitment to GUY-T-MOHP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health of the Co-operative Republic of Guyana 159026.89 Global Fund commitment to GUY-T-MOHP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health of the Co-operative Republic of Guyana -2827.09 Global Fund commitment to GUY-T-MOHP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health of the Co-operative Republic of Guyana 73073.91 Global Fund disbursement to GUY-T-MOHP02 (Government). The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health of the Co-operative Republic of Guyana 34680.75 Global Fund disbursement to GUY-T-MOHP02 (Government). The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health of the Co-operative Republic of Guyana 25000.00 Global Fund disbursement to GUY-T-MOHP02 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health of the Co-operative Republic of Guyana 51272.23 Global Fund disbursement to GUY-T-MOHP02 (Government). The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health of the Co-operative Republic of Guyana 25000.00 Global Fund commitment to GUY-T-MOHP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health of the Co-operative Republic of Guyana 68100.99 Global Fund commitment to GUY-T-MOHP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health of the Co-operative Republic of Guyana 68100.99 Global Fund disbursement to GUY-T-MOHP02 (Government). The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health of the Co-operative Republic of Guyana 627.11 Funds returned to the Global Fund from GUY-T-MOHP02 (Other 3rd Party). Ministry of Health of the Co-operative Republic of Guyana The Global Fund to Fight AIDS, Tuberculosis and Malaria -627.11 Global Fund commitment to GUY-T-MOHP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health of the Co-operative Republic of Guyana 25000.00 Global Fund disbursement to GUY-T-MOHP02 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health of the Co-operative Republic of Guyana 1146.74 Funds returned to the Global Fund from GUY-T-MOHP02 (Government). Ministry of Health of the Co-operative Republic of Guyana The Global Fund to Fight AIDS, Tuberculosis and Malaria -1146.74 Global Fund commitment to GUY-T-MOHP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health of the Co-operative Republic of Guyana 31335.14 Expenditure reported by Ministry of Health of the Co-operative Republic of Guyana for GUY-T-MOHP02, Apr 2019 to Dec 2019. Ministry of Health of the Co-operative Republic of Guyana 118588.23 Expenditure reported by Ministry of Health of the Co-operative Republic of Guyana for GUY-T-MOHP02, Jan 2020 to Dec 2020. Ministry of Health of the Co-operative Republic of Guyana 128493.38 Expenditure reported by Ministry of Health of the Co-operative Republic of Guyana for GUY-T-MOHP02, Jan 2021 to Dec 2021. Ministry of Health of the Co-operative Republic of Guyana 32408.08 Expenditure reported by Ministry of Health of the Co-operative Republic of Guyana for GUY-T-MOHP02, Jan 2022 to Jun 2022. Ministry of Health of the Co-operative Republic of Guyana <narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime. <narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Module: MDR-TB. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Geographic coverage: National. Aggregation: Cumulative annually. <narrative>Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative> Module: RSSH: Health management information systems and M&E. <narrative>Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 20; Denominator: 25. Numerator: 21; Denominator: 25. Numerator: 21; Denominator: 24. Numerator: 23; Denominator: 25. Numerator: 21; Denominator: 25. Numerator: 25; Denominator: 28. Numerator: 23; Denominator: 26. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Module: TB care and prevention. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Geographic coverage: National. Aggregation: Cumulative annually. <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative> Module: TB care and prevention. <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 15; Denominator: 19. Numerator: 19; Denominator: 19. Numerator: 16; Denominator: 18. Numerator: 19; Denominator: 19. Numerator: 7; Denominator: 16. Numerator: 19; Denominator: 19. Numerator: 7; Denominator: 14. <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative> Module: TB care and prevention. <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 390; Denominator: 563. Numerator: 525.3; Denominator: 618. Numerator: 362; Denominator: 504. Numerator: 564.3; Denominator: 627. Numerator: 345; Denominator: 481. Numerator: 544.5; Denominator: 605. Numerator: 239; Denominator: 358. <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Module: TB/HIV. <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 108; Denominator: 131. Numerator: 103; Denominator: 121. Numerator: 70; Denominator: 82. Numerator: 95; Denominator: 106. Numerator: 34; Denominator: 44. Numerator: 85; Denominator: 89. Numerator: 53; Denominator: 65. <narrative>Percentage of people living with HIV newly enrolled in HIV care started on TB preventive therapy</narrative> Module: TB/HIV. <narrative>Percentage of people living with HIV newly enrolled in HIV care started on TB preventive therapy</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 91; Denominator: 641. Numerator: 540; Denominator: 1080. Numerator: 329; Denominator: 607. Numerator: 572; Denominator: 763. Numerator: 303; Denominator: 369. Numerator: 273; Denominator: 303. Numerator: 245; Denominator: 459.